If there is one thing we have been impatiently waiting for, it is a COVID-19 vaccine. In a world’s first, Britain approved Pfizer’s COVID-19 vaccine. The U.K. became one of the first western countries to endorse a jab. All the vulnerable people of the U.K. will start getting vaccinated from early next week. The vaccine comes as a ray of hope amid the gloom of the global pandemic that killed nearly 1.5 million people globally and upended everyday life.
The Vaccine Is 95% Effective
Britain’s Medicines and Healthcare products Regulatory Agency claim that the Pfizer-BioNTech vaccine is 95% effective in preventing illness, in record time. While the most significant powers of the world have been racing for a vaccine for months, it is U.K. who made the checkmate. The vaccine will finally allow the country to reclaim our lives and get the economy moving again. Half A Million Sharks Might Be Killed For COVID Vaccine, Experts Warn.
Vaccines Will Be Given To The Vulnerable From Next Week
The approval of a vaccine almost a year since the novel coronavirus emerged in Wuhan, China, is a triumph for science. While the British leaders said that they would want to get a jab themselves, they would give priority to the elderly and those in care homes and health workers. Now coming to the potential risk of the vaccine, with hundreds dying of the infection every day, the benefits of the vaccine approval outweigh the potential risks. Mumbai Travel Company Is Offering A Holiday To The USA At ₹1.75 Lakhs Including A COVID-19 Vaccine.
Britain To Receive 800,000 Doses Of The Vaccine
Britain said it would start vaccinating the vulnerable from next week after it receives 800,000 doses from Pfizer’s manufacturing centre in Belgium. However, the speed of the rollout depends on how fast Pfizer can manufacture and deliver the vaccine. Every individual will need two shots to gain immunity. Britain has ordered 40 million doses of the Pfizer vaccine enough for just under a third of the population.
Other frontrunners in the vaccine race include U.S. biotech firm Moderna, and AstraZeneca.